Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 03:26:56 2024-05-02 pm EDT			5-day change	1st Jan Change
0.27 ^USD	-6.90%		+35.00%	+99.26%

Apr. 16	Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 19	Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	CI

Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD

January 31, 2024 at 08:30 am EST

Ludwig Enterprises, Inc. announced that the company has received Continuing Review Approval on its planned clinical study from Advarra IRB, Columbia, MD. Ludwig clinical study LL301 is titled: "Using Measurements of mRNA and Elisa- based Cytokine/Protein Indices to Evaluate Pre- and Post-Diagnosis and Treatment Response of Patients with Urothelial Carcinoma of the Bladder".

Latest news about Ludwig Enterprises, Inc.

Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	Mar. 19	CI
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	Mar. 06	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	Feb. 11	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	Jan. 31	CI
Ludwig Enterprises, Inc. Announces Executive Changes	Dec. 01	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	Nov. 16	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	23-09-19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	23-04-25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	23-04-12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	23-02-14	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	23-01-03	CI
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22-09-22	CI
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study	22-09-20	CI
Ludwig Enterprises, Inc. Appoints Dr. Kyle Ambert to Scientific Advisory Board	22-07-21	CI
Ludwig Enterprises, Inc. Appoints Anne Blackstone as Director	22-07-12	CI
Ludwig Enterprises, Inc. Appoints Anne Blackstone as Chief Executive Officer	22-07-12	CI
Ludwig Enterprises, Inc. acquired Direct Mortgage Investors, Inc.	19-12-18	CI
Ludwig Enterprises Inc. acquired Floss Publishing, Inc.	14-04-23	CI
Ludwig Enterprises, Inc., Opens Acquisition Talks With Floss Publishing, Inc.	14-03-03	CI
Ludwig Enterprises Inc. Announces Joint Venture Agreement with Worthington Financial Services, Inc	12-10-17	CI
Ludwig Enterprises Inc. Announces Definitive Agreement for Technology Deployment in South Korea	12-07-31	CI

Chart Ludwig Enterprises, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data